NYSE:STE - New York Stock Exchange, Inc. - IE00BFY8C754 - Common Stock - Currency: USD
220.56
-0.23 (-0.1%)
The current stock price of STE is 220.56 USD. In the past month the price increased by 1.55%. In the past year, price decreased by -6.48%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
STERIS Plc engages in the provision of healthcare and life science products and service solutions. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
STERIS PLC
Block a Riverside IV, 70 Sir John Rogerson's Quay
DUBLIN D02 R296 IE
CEO: Walter M Rosebrough
Employees: 18179
Company Website: https://www.steris.com/
Investor Relations: https://sterisplc.gcs-web.com
Phone: 35312322000
The current stock price of STE is 220.56 USD. The price decreased by -0.1% in the last trading session.
The exchange symbol of STERIS PLC is STE and it is listed on the New York Stock Exchange, Inc. exchange.
STE stock is listed on the New York Stock Exchange, Inc. exchange.
12 analysts have analysed STE and the average price target is 257.93 USD. This implies a price increase of 16.94% is expected in the next year compared to the current price of 220.56. Check the STERIS PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
STERIS PLC (STE) has a market capitalization of 21.67B USD. This makes STE a Large Cap stock.
STERIS PLC (STE) currently has 18179 employees.
STERIS PLC (STE) has a support level at 218.34 and a resistance level at 220.88. Check the full technical report for a detailed analysis of STE support and resistance levels.
The Revenue of STERIS PLC (STE) is expected to grow by 0.76% in the next year. Check the estimates tab for more information on the STE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
STERIS PLC (STE) has a dividend yield of 1.03%. The yearly dividend amount is currently 2.03. Check the full fundamental report for a detailed analysis of STE dividend history, reliability and sustainability.
STERIS PLC (STE) will report earnings on 2025-05-06, after the market close.
The PE ratio for STERIS PLC (STE) is 24.03. This is based on the reported non-GAAP earnings per share of 9.18 and the current share price of 220.56 USD. Check the full fundamental report for a full analysis of the valuation metrics for STE.
The outstanding short interest for STERIS PLC (STE) is 1.01% of its float. Check the ownership tab for more information on the STE short interest.
ChartMill assigns a technical rating of 3 / 10 to STE. When comparing the yearly performance of all stocks, STE is a bad performer in the overall market: 64.34% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to STE. STE scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months STE reported a non-GAAP Earnings per Share(EPS) of 9.18. The EPS increased by 7.37% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 9.18% | ||
ROA | 4.67% | ||
ROE | 7.27% | ||
Debt/Equity | 0.32 |
ChartMill assigns a Buy % Consensus number of 78% to STE. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 3.66% and a revenue growth 0.76% for STE